AstraZeneca Announced Tezspire Approved For Self-administration In The EU In A New Pre-filled Pen
AstraZeneca's Tezspire (tezepelumab) has received a positive opinion from the European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP) for self-administration in a pre-filled, single-use pen for patients aged 12 years and older with severe asthma.
Reported Late Wednesday, Oramed Pharmaceuticals Announces Top-line Results From Phase 3 Trial Of ORMD-0801 For The Treatment Of Type 2 Diabetes
Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, announced today top-line results from its Phase 3 randomized,
‘HH&L Acquisition Co SPAC Merger Company DiaCarta Gets FDA Emergency Use Authorization For Its Quantivirus Monkeypox Test Kit’ – FDA
https://www.fda.gov/media/164470/download
What’s Going On With Biora Therapeutics Stock?
Biora Therapeutics Inc (NASDAQ: BIOR) shares are trading higher on abnormally-high volume Wednesday. Here's a look at what's going on.
Airsupra (PT027) Approved In U.S. For asthma
https://news.cision.com/se/astrazeneca/r/airsupra--pt027--approved-in-the-us-for-asthma%2Cc3696063
Reported Late Tuesday, MediciNova Receives A Notice Of Allowance For A New Patent Covering MN-001 And MN-002 For The Treatment Of Scleroderma And Systemic Sclerosis In Canada
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it has received a Notice of Allowance
‘I sent a letter today to the CEO of Moderna with a simple message: In the midst of a public health crisis, quadrupling the price of a publicly-funded COVID-19 vaccine is unacceptable corporate greed.’ -Bernie Sanders Tweet
https://twitter.com/SenSanders/status/1612858617631313945
Silo Pharma Advances Clinical Study Analyzing Effects Of Psilocybin On Inflammation
Parkinson's disease, bipolar disorder, and chronic pain targeted in study
Study aims to support psilocybin as a potential therapeutic for inflammatory disorders
Israel-Based Clearmind Medicine Successfully Completes Production Of CMND-100 Drug Candidate For Clinical Trial
Clearmind Medicine Inc. (NASDAQ:CMND) (CSE:CMND) (FSE: CWY) ("Clearmind" or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve